DxLab Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 6

DxLab General Information

Description

Developer of a portable molecular testing system designed for rapid and affordable infectious disease diagnostics. The company offers a compact molecular testing platform, point-of-care infectious disease tests, and multiplex molecular testing technology, enabling public health and healthcare applications outside complex laboratory settings.

Contact Information

Website
www.dxlab.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 100 Chestnut Street
  • Suite 300
  • Somerville, MA 02143
  • United States
+1 (857)
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • 100 Chestnut Street
  • Suite 300
  • Somerville, MA 02143
  • United States
+1 (857)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DxLab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 23-Sep-2024 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2024 Completed Startup
3. Accelerator/Incubator 08-Dec-2022 Completed Startup
2. Seed Round 23-Dec-2020 $4M $4M Completed Startup
1. Accelerator/Incubator 22-Oct-2020 Completed Startup
To view DxLab’s complete valuation and funding history, request access »

DxLab Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view DxLab’s complete cap table history, request access »

DxLab Patents

DxLab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022205595-A1 Methods for detection of nucleic acids Pending 05-Jan-2021
AU-2022205595-A9 Methods for detection of nucleic acids Pending 05-Jan-2021
CA-3204128-A1 Methods for detection of nucleic acids Pending 05-Jan-2021
EP-4274912-A2 Methods for detection of nucleic acids Pending 05-Jan-2021
EP-4274912-A4 Methods for detection of nucleic acids Pending 05-Jan-2021 C12Q1/701
To view DxLab’s complete patent history, request access »

DxLab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DxLab Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Unlock Capital (New York) Accelerator/Incubator
Mentor Capital Network Accelerator/Incubator
MIT Startup Exchange Accelerator/Incubator
E14 Fund Venture Capital Minority
Neoteny Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

DxLab FAQs

  • When was DxLab founded?

    DxLab was founded in 2020.

  • Where is DxLab headquartered?

    DxLab is headquartered in Somerville, MA.

  • What is the size of DxLab?

    DxLab has 3 total employees.

  • What industry is DxLab in?

    DxLab’s primary industry is Diagnostic Equipment.

  • Is DxLab a private or public company?

    DxLab is a Private company.

  • What is DxLab’s current revenue?

    The current revenue for DxLab is .

  • How much funding has DxLab raised over time?

    DxLab has raised $4M.

  • Who are DxLab’s investors?

    Unlock Capital (New York), Mentor Capital Network, MIT Startup Exchange, E14 Fund, and Neoteny are 5 of 6 investors who have invested in DxLab.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process